/Companies

Benchsci

Toronto, US · Founded 2015 · 211 employees on LinkedIn · 15 known investors

Find your way into Benchsci

Each arrow is one introduction. Sign up to fill in the first one.

1,153 people can intro you to Liran

Ask Tim McAdam to introduce you to Liran Belenzon

You →Tim · together at Benchsci →Liran

982 people can intro you to Tom

Ask Jamie Chen to introduce you to Tom Leung

You →Jamie · together at Benchsci →Tom

Sign up to find every way you can get introduced to Benchsci

  • Your email: who you already know at Benchsci, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Benchsci team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.

Founders & leadership

Benchsci was founded in 2015 by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, Tom Leung, and David Chen.

DQDavid Qixiang Chen, PhD
David Qixiang Chen, PhDCo-Founder, Chief Innovation Officer (CINO), Director of AI2020–2020
EW
Elvis WiandaCo-founder · Chief Data Officer
LBLiran Belenzon
Liran BelenzonFounder and CEOHe previously served as a commander in the Israel Defense Forces and founded an e-commerce B2B marketplace in Israel; he earned an MBA from the University of Toronto's Rotman School of Management.
TLTom Leung
Tom LeungCo-founder & Chief Science OfficerTom Leung is Co-founder and Chief Science Officer of BenchSci, which develops AI-powered tools for preclinical drug discovery by extracting experimental evidence from scientific literature to help researchers select reagents and model systems.
DCDavid Chen
David ChenCo-founder

Investors · 15

500 Globallisted by 500 GlobalPalo Alto · $150K

How we know: open dataset · 500 Global portfolio 2026-08 · Not right? Tell us

Frequently asked questions

What does Benchsci do?
BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.
Who founded Benchsci?
Benchsci was founded by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, Tom Leung, David Chen in 2015.
Who are Benchsci's investors?
Benchsci's investors include Inovia Capital, Generation Investment Management, Gradient Ventures, TCV, 500 Global, Afore Capital, BDC Growth Venture Fund, Creative Destruction Lab (CDL) and 7 more.
Where is Benchsci headquartered?
Benchsci is headquartered in Toronto, US.